Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors

Breast Cancer Research and Treatment

Volumn 97, Issue 1, 2006, Pages 3-8

  Al Abbadi, M A ^a,b   Washington, T A ^a   Saleh, H A ^a   Tekyi Mensah, S E ^a   Lucas, D R ^a   Briston, C A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast; Carcinoma; Detroit; Her 2 neu; Race; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CAUCASIAN; ETHNOLOGY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; UNITED STATES; URBAN AREA;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MICHIGAN; MIDDLE AGED; NEOPLASM INVASIVENESS; PREVALENCE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33646755153     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-5149-z     Document Type: Article

References (31)

1. Bundred NJ: Prognostic and predictive factors in breast cancer. Cancer Treat Rev 27: 137-142, 2001
2. Kaptain S, Tan LK, Chen B: Her-2/neu and breast cancer. Diagn Mol Pathol 10: 139-152, 2001
3. Ravdin PM, Chamness GC: The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene 159: 19-27, 1995
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
5. Bernstein JL, Lopez-Carrillo L, Wang L: The epidemiology of Her-2/neu and P53 in breast cancer. Salud Publica Mex 41(Suppl 2), S114-S123, 1999
6. Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705-712, 1994
7. Ameyaw MM, Tayeb M, Thornton N, Folayan G, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, McLead HL: Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 47: 172-175, 2002
8. Jukkola A, Bloigu R, Soini Y, Savolainen ER, Holli K, Blanco G: c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease. Eur J Cancer 37: 347-354, 2001
9. Menard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, Cascinelli N: HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res 8: 520-525, 2002
10. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894-2904, 1997
11. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S: Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol 79: 216-223, 2002
12. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947-954, 1994
13. Joslyn SA, West MM: Racial differences in breast carcinoma survival. Cancer 88: 114-123, 2000
14. Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen VW: Use of coping strategies and breast cancer survival: results from the Black/White Cancer Survival Study. Am J Epidemiol 152: 940-949, 2000
15. Li A., Burton G, Glass J: Breast cancer: a socioeconomic and racial comparison in northwest Louisiana. J La State Med Soc 153: 420-425, 2001
16. O'Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J: The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening?. Am J Public Health 91: 49-54, 2001
17. Breen N, Wesley MN, Merrill RM, Johnson K: The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis 9: 111-125, 1999
18. Rose DP, Royak-Schaler R: Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 25: 16-31, 2001
19. Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B: Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol 153: 284-291, 2001
20. Millikan R, DeVoto E, Duell EJ, Tse CK, Savitz DA, Beach J, Edmiston S, Jackson S, Newman B: Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 9: 1233-1240, 2000
21. Gao Q, Adebamowo CA, Fackenthal J: Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 107: 192-194, 2000
22. Gao Q, Tomlinson G, Das S, Cummings S, Sveen L, Fackenthal J, Schumm P, Olopade OI: Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 107: 186-191, 2000
23. Shen D, Wu Y, Subbarao M, Bhat H, Chillar R, Vadgama JV: Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 92: 29-35, 2000
24. Dangel J, Wagner-Costalas J, Bove B, Vanderveer L, Itzen M, Daly M, Godwin AK: Novel germline BRCA1 mutation (155del4) in an African American with early-onset breast cancer. Hum Mutat 14: 545, 1999
25. Wojcik BE, Spinks MK, Optenberg SA: Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82: 1310-1318, 1998
26. Bibb SC: The relationship between access and stage at diagnosis of breast cancer in African American and Caucasian women. Oncol Nurs Forum 28: 711-719, 2001
27. Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Durme DJ Van, Krischer JP: Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 89: 2202-2213, 2000
28. Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22: 436-440, 1999
29. Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Amberson JB, Bratton J: Ethnic differences in risk and prognostic factors for breast cancer. Cancer 76: 268-274, 1995
30. Koduri S, Fuqua SA, Poola I: Alterations in the estrogen receptor alpha mRNA in the breast tumors of African American women. J Cancer Res Clin Oncol 126: 291-297, 2000
31. Haerslev T, Jacobsen GK: c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study. Apmis 102: 612-622, 1994